Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Halogenated inhalational anaesthetics.

Florian M Reichle1, Peter F Conzen

  • 1Department of Anaesthesiology, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany. florian.reichle@helios.med.uni-muenchen.de

Best Practice & Research. Clinical Anaesthesiology
|May 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ischemia-reperfusion-induced unmeasured anion generation and glycocalyx shedding: sevoflurane versus propofol anesthesia.

Journal of investigative surgery : the official journal of the Academy of Surgical Research·2012
Same author

Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects.

Current opinion in investigational drugs (London, England : 2000)·2008
Same author

Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery.

Anesthesiology·2003
Same author

Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency.

Anesthesiology·2002
Same author

Nephrotoxicity of halogenated inhalational anaesthetics: fictions and facts.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2002
Same journal

Reimagining cardiac surgery-the emerging role of prehabilitation and risk optimization.

Best practice & research. Clinical anaesthesiology·2026
Same journal

Prehabilitation and enhanced recovery after cardiac surgery.

Best practice & research. Clinical anaesthesiology·2026
Same journal

The role of biomarkers in the preoperative evaluation of cardiac surgical patients - A narrative review.

Best practice & research. Clinical anaesthesiology·2026
Same journal

Magic in a bottle? A Focused review of factor concentrates for the intraoperative treatment of acquired coagulopathy - Fibrinogen concentrate, prothrombin complex concentrate, and recombinant activated factor VII.

Best practice & research. Clinical anaesthesiology·2025
Same journal

ESAs in perioperative anemia management: Who, what, how and why?

Best practice & research. Clinical anaesthesiology·2025
Same journal

Does patient blood management represent good value for money?

Best practice & research. Clinical anaesthesiology·2025
See all related articles

Halogenated anesthetics can cause liver injury through metabolic activation. Post-operative immune hepatitis risk varies, being lower with enflurane, isoflurane, and desflurane compared to halothane.

Area of Science:

  • Anesthesiology
  • Immunology
  • Hepatology

Background:

  • Halogenated inhalational anesthetics (halothane, enflurane, isoflurane, desflurane, sevoflurane) are associated with potential organ toxicity.
  • Metabolism of these agents can lead to reactive intermediates, protein acetylation, and neo-antigen formation.
  • Concerns include metabolic hepatocellular injury, immune-mediated hepatitis, and nephrotoxicity from fluoride or degradation products like compound A.

Purpose of the Study:

  • To review the metabolic pathways and potential toxicities of halogenated inhalational anesthetics.
  • To compare the risks of liver injury and nephrotoxicity associated with different anesthetic agents.
  • To evaluate the clinical significance of anesthetic degradation products.

Main Methods:

Related Experiment Videos

  • Review of existing literature on the metabolism and toxicity of halogenated inhalational anesthetics.
  • Analysis of studies investigating hepatocellular injury, immune responses, and nephrotoxicity.
  • Examination of data on plasma fluoride levels and compound A formation and effects.

    • Main Results:

    • Metabolic acetylation of anesthetics can form neo-antigens, potentially triggering immune responses and post-operative immune hepatitis.
    • The risk of immune hepatitis is significantly lower with enflurane, isoflurane, and desflurane compared to halothane due to lower metabolism.
    • While sevoflurane increases plasma inorganic fluoride, it has not been linked to nephrotoxicity in humans; compound A, a degradation product, shows rodent nephrotoxicity but not significant renal effects in surgical patients.

    Conclusions:

    • Halogenated anesthetics carry a risk of metabolic hepatocellular injury and immune-mediated hepatitis, with risk varying by agent.
    • Sevoflurane-induced hyperfluoridemia does not appear to cause nephrotoxicity in humans.
    • Compound A poses a theoretical risk but has not demonstrated significant renal toxicity in clinical settings.